Sugimoto K et al. |
Assessment of Long-Term Efficacy and Safety of Adalimumab in Patients with Ulcerative Colitis: Results from a 6-Year Real-World Clinical Practice. |
2019 |
Dig Dis |
pmid:30205400
|
Gaynor JJ and Ciancio G |
The Importance of Using Serially Measured Tacrolimus Clearance Values, Especially During the Early Posttransplantation Period. |
2018 |
Transplantation |
pmid:29271869
|
Cho EJ et al. |
Performance of the Dimension TAC assay and comparison of multiple platforms for the measurement of tacrolimus. |
2018 |
J. Clin. Lab. Anal. |
pmid:29148096
|
Sir G et al. |
Antagonistic Effect of Oxytocin and Tacrolimus Combination on Adipose Tissue - Derived Mesenchymal Stem Cells: Antagonistic effect of oxytocin and tacrolimus. |
2018 |
Biomed. Pharmacother. |
pmid:29136956
|
Felipe C et al. |
Adequacy of Initial Everolimus Dose, With and Without Calcineurin Inhibitors, in Kidney Transplant Recipients. |
2018 |
Ther Drug Monit |
pmid:29271815
|
Kimura Y et al. |
Profiling the immunotoxicity of chemicals based on in vitro evaluation by a combination of the Multi-ImmunoTox assay and the IL-8 Luc assay. |
2018 |
Arch. Toxicol. |
pmid:29594315
|
Loeschenberger B et al. |
Calcineurin inhibitor-induced complement system activation via ERK1/2 signalling is inhibited by SOCS-3 in human renal tubule cells. |
2018 |
Eur. J. Immunol. |
pmid:29143318
|
Özçakar ZB et al. |
Transplantation within the era of anti-IL-1 therapy: case series of five patients with familial Mediterranean fever-related amyloidosis. |
2018 |
Transpl. Int. |
pmid:29957882
|
Chao YH et al. |
Tolerogenic β2-glycoprotein I DNA vaccine and FK506 as an adjuvant attenuates experimental obstetric antiphospholipid syndrome. |
2018 |
PLoS ONE |
pmid:29894515
|
Sablik KA et al. |
Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection. |
2018 |
PLoS ONE |
pmid:29746495
|
Tang JT et al. |
A Low Fixed Tacrolimus Starting Dose Is Effective and Safe in Chinese Renal Transplantation Recipients. |
2018 |
Ann. Transplant. |
pmid:29735966
|
Cai W et al. |
Limited Sampling Strategy for Estimating Mycophenolic Acid Exposure on Day 7 Post-Transplant for Two Mycophenolate Mofetil Formulations Derived From 20 Chinese Renal Transplant Recipients. |
2018 |
Transplant. Proc. |
pmid:29735215
|
Zhang Y and Zhang R |
Recent advances in analytical methods for the therapeutic drug monitoring of immunosuppressive drugs. |
2018 |
Drug Test Anal |
pmid:28851030
|
Thishya K et al. |
Artificial neural network model for predicting the bioavailability of tacrolimus in patients with renal transplantation. |
2018 |
PLoS ONE |
pmid:29621269
|
Riva N et al. |
Survival Time to Biopsy-Proven Acute Rejection and Tacrolimus Adverse Drug Reactions in Pediatric Liver Transplantation. |
2018 |
Ther Drug Monit |
pmid:29621122
|
Goto T et al. |
Prospective observational study on the first 51 cases of peripheral blood stem cell transplantation from unrelated donors in Japan. |
2018 |
Int. J. Hematol. |
pmid:29027623
|
Liu J et al. |
Donor and recipient P450 gene polymorphisms influence individual pharmacological effects of tacrolimus in Chinese liver transplantation patients. |
2018 |
Int. Immunopharmacol. |
pmid:29454235
|
Choi CB et al. |
Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis. |
2018 |
Lupus |
pmid:29448881
|
Woodworth MH et al. |
Tacrolimus concentration to dose ratio in solid organ transplant patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. |
2018 |
Transpl Infect Dis |
pmid:29446866
|
Buchholz BM et al. |
Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients. |
2018 |
World J. Gastroenterol. |
pmid:30065563
|